ArticleArchives of sexual behavior2026
Self-Reported Psychosis Spectrum Symptoms Among Sexual and Gender Diverse Emerging Adults Screened for a Suicide Prevention Trial.
Article in Archives of sexual behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Psychosis spectrum symptoms, including a range of unusual thoughts and perceptual abnormalities, are markers of increased vulnerability to psychotic disorders. Sexual and gender diverse (SGD) populations experience higher rates of psychotic disorders than the general population, raising the possibility that emerging adult SGD individuals may also report elevated psychosis spectrum experiences. We hypothesized that SGD emerging adults would report higher rates of psychosis spectrum symptoms than the general population. In line with intersectional frameworks, we further hypothesized that rates would be higher among individuals with multiple marginalized identities. We screened SGD emerging adults (ages 18-24; N = 376) for a clinical trial of a mobile health intervention to decrease suicide risk. A brief eligibility screening questionnaire assessed racial, ethnic, sexual, and gender identities. The Diagnostic Interview for Anxiety, Mood, and OCD and Related Neuropsychiatric Disorders (DIAMOND) psychosis screener questions were used to assess self-reported unusual thoughts and perceptual abnormalities. Psychosis spectrum symptoms were reported by 40% of the screened sample versus 23% in the general population. The probability of endorsing symptoms (OR = 1.528, 95% CI = 1.16-1.99, p = 0.002) increased with each additional minority status identification (i.e., race, ethnicity, sexual identity, gender identity). Future research should explore unique factors contributing to the heightened rates of self-reported psychosis spectrum symptoms among these minority populations and attempt to test the replicability of these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.